{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T16:40:03Z","timestamp":1715964003295},"reference-count":54,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Cardiol."],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1517\/14796678.1.3.289","type":"journal-article","created":{"date-parts":[[2005,6,8]],"date-time":"2005-06-08T12:50:40Z","timestamp":1118235040000},"page":"289-297","source":"Crossref","is-referenced-by-count":0,"title":["Rosuvastatin: Achieving Cholesterol Targets"],"prefix":"10.1080","volume":"1","author":[{"given":"Allan","family":"Gaw","sequence":"first","affiliation":[{"name":"Clinical Trials Unit 4th Floor\rWalton Building\rGlasgow Royal Infirmary,Glasgow\rG4 0SF\rUK."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,11,24]]},"reference":[{"key":"e_1_3_1_3_1_1","first-page":"1383","volume":"344","author":"Scandinavian S","year":"1994","unstructured":"Scandinavian S imvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4,444 patients with CHD: the Scandinavian Simvastatin Survival Study (4S). Lancet, 344, 1383\u20131389 (1994).","journal-title":"Lancet"},{"key":"e_1_3_1_3_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610033351401"},{"key":"e_1_3_1_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811053391902"},{"key":"e_1_3_1_3_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511163332001"},{"key":"e_1_3_1_3_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.20.1615"},{"key":"e_1_3_1_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"e_1_3_1_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11600-X"},{"key":"e_1_3_1_3_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"e_1_3_1_3_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/174182670301000101"},{"key":"e_1_3_1_3_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040583"},{"key":"e_1_3_1_3_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133317.49796.0E"},{"key":"e_1_3_1_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)01454-0"},{"key":"e_1_3_1_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)80185-9"},{"key":"e_1_3_1_3_14_1","unstructured":"CRESTOR I nternational Product Monograph AstraZeneca 6962 April (2003)."},{"key":"e_1_3_1_3_15_1","first-page":"T7","volume":"1","author":"Horsmans","year":"1999","unstructured":"Horsmans Y: Differential metabolism of statins: importance of drug\u2013drug interactions. Eur. Heart J., 1(Suppl. T), T7\u2013T12 (1999).","journal-title":"Eur. Heart J."},{"key":"e_1_3_1_3_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-002-0508-8"},{"key":"e_1_3_1_3_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01720.x"},{"key":"e_1_3_1_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(02)17633-8"},{"key":"e_1_3_1_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80089-9"},{"key":"e_1_3_1_3_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270002042012008"},{"key":"e_1_3_1_3_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.02015.x"},{"key":"e_1_3_1_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.12.014"},{"key":"e_1_3_1_3_23_1","unstructured":"Simonson S et al.: Rosuvastatin pharmacokinetics in heart-transplant recipients administered cyclosporin. Proc. 6th EACPT Congress Istanbul 135 [Abstract] P-240 (2004)."},{"key":"e_1_3_1_3_24_1","unstructured":"CRESTOR\u00ae (rosuvastatin calcium) Prescribing Information. Wilmington DE: AstraZeneca Pharmaceuticals LP (2003)."},{"key":"e_1_3_1_3_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/009127002401382722"},{"key":"e_1_3_1_3_26_1","unstructured":"CRESTOR UK Summary of Product Characteristics Updated 19th December 2004 Astra Zeneca."},{"key":"e_1_3_1_3_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-002-0541-7"},{"key":"e_1_3_1_3_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.2002.tb00099.x"},{"key":"e_1_3_1_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00530-7"},{"key":"e_1_3_1_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehjsup.2004.01.004"},{"key":"e_1_3_1_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2003.10.004"},{"key":"e_1_3_1_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5688(04)90462-5"},{"key":"e_1_3_1_3_33_1","first-page":"118","volume":"5","author":"Wolfenbuttel","year":"2004","unstructured":"Wolfenbuttel BHR et al.: Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with Type 2 diabetes. Atheroscler. Suppl., 5, 118(M.513) (2004).","journal-title":"Atheroscler. Suppl."},{"key":"e_1_3_1_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5688(04)90461-3"},{"key":"e_1_3_1_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.08.009"},{"key":"e_1_3_1_3_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.09.034"},{"key":"e_1_3_1_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.02.002"},{"key":"e_1_3_1_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00003-1"},{"key":"e_1_3_1_3_39_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.5.5.1187"},{"key":"e_1_3_1_3_40_1","first-page":"713","volume":"18","author":"Fellstr\u00f6m","year":"2003","unstructured":"Fellstr\u00f6m B, Zannad F, Schmeider R et al.: A study to evaluate the use of rosuvastatin in subjects on regular haemodialysis: an assessment of survival and cardiovascular events \u2013 the AURORA study. Nephrol. Dial. Transplant, 18(Suppl. 4), 713 (2003).","journal-title":"Nephrol. Dial. Transplant"},{"key":"e_1_3_1_3_41_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000100688.17280.E6"},{"key":"e_1_3_1_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2004.03.001"},{"key":"e_1_3_1_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.06.049"},{"key":"e_1_3_1_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00779-3"},{"key":"e_1_3_1_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02030-2"},{"key":"e_1_3_1_3_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200202143460721"},{"key":"e_1_3_1_3_47_1","first-page":"1","article-title":"Epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs. In: Rainsford KD, Velo GP (Eds)","author":"Weber JCP","year":"1984","unstructured":"Weber JCP : Epidemiology of adverse reactions to nonsteroidal anti-inflammatory drugs. In: Rainsford KD, Velo GP (Eds)Advances in Inflammation Research. Vol. 6. New York, NY, Raven Press 1\u20137 (1984).","journal-title":"Advances in Inflammation"},{"key":"e_1_3_1_3_48_1","doi-asserted-by":"publisher","DOI":"10.1159\/000077704"},{"key":"e_1_3_1_3_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000143720.71748.79"},{"key":"e_1_3_1_3_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000136778.32499.05"},{"key":"e_1_3_1_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00965-X"},{"key":"e_1_3_1_3_52_1","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.1.4.495"},{"key":"e_1_3_1_4_2_1","unstructured":"www.fda.gov\/cder\/drug\/advisory\/crestor_3_2005.htm (Accessed April2005)"},{"key":"e_1_3_1_4_3_1","unstructured":"www.rosuvastatininformation.com (Accessed April2005)"}],"container-title":["Future Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14796678.1.3.289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T16:21:22Z","timestamp":1715962882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14796678.1.3.289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1517\/14796678.1.3.289"],"URL":"https:\/\/doi.org\/10.1517\/14796678.1.3.289","relation":{},"ISSN":["1479-6678","1744-8298"],"issn-type":[{"value":"1479-6678","type":"print"},{"value":"1744-8298","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}